Nektar Therapeutics · NASDAQ:NKTR
Robin Howard W sold 418 Nektar Therapeutics shares (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Robin Howard W (Director, President & CEO) sold 418 Nektar Therapeutics shares at US$71.98 for US$30,088, leaving 54,627 shares. Filed Aug 20, 2026 (Form 4).
- Sold
- 418 shares
- Price
- US$71.98
- Value
- US$30,088
- Holding after
- 54,627 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Sale | 418 | US$71.98 | 54,627 | Direct |
Source
Related
- Nektar Therapeutics
- Robin Howard W
- Nektar Therapeutics shareholders
- Form 4 · Robin Howard W · Jun 18, 2026
- Form 4 · Robin Howard W · May 21, 2026
- Schedule 13G/A · Two Seas Capital LP · Sep 28, 2026
- Form 4 · Whitfield Roy A · Sep 25, 2026
- Form 4 · Greer R Scott · Sep 25, 2026
- Form 4 · Chess Robert · Sep 25, 2026
- Form 4 · Brainard Diana · Sep 25, 2026